Call Options Transactions Made in Q2 2025 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q2 2025. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
204K+ 310.37% |
$586K - $735K
|
269K
$915K
|
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
33.3K+ 87.86% |
$95.9K - $120K
|
71.2K
$242K
|
|
|
Aug 18, 2025
Q2 2025
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
17.3K+ 64.79% |
$49.8K - $62.5K
|
44K
$150K
|
|
|
Aug 13, 2025
Q2 2025
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
CALL |
9.3KNew |
$26.8K - $33.6K
|
9.3K
$31.6K
|
|
|
Aug 12, 2025
Q2 2025
|
Eisler Capital Management Ltd.
London, X0 |
BUY
|
CALL |
3.2K+ 2.67% |
$9.22K - $11.6K
|
123K
$419K
|
|
|
Aug 11, 2025
Q2 2025
|
Citigroup Inc
|
SELL
|
CALL |
-5K- 1.39% |
$14.4K - $18.1K
|
355K
$1.21M
|
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
CALL |
-28.2K- 50.45% |
$81.2K - $102K
|
27.7K
$94.2K
|